The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Clinical trial NCT06214195 · RECRUITING
Trial details
- NCT number
- NCT06214195
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-20
- Primary completion
- 2026-12-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.